Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Priscila C, Teixeira"'
Autor:
Pauline Brochet, Barbara Ianni, João P. S. Nunes, Amanda F. Frade, Priscila C. Teixeira, Charles Mady, Ludmila R. P. Ferreira, Andreia Kuramoto, Cristina W. Pissetti, Bruno Saba, Darlan D. S. Cândido, Fabrício Dias, Marcelo Sampaio, José A. Marin-Neto, Abílio Fragata, Ricardo C .F. Zaniratto, Sergio Siqueira, Giselle D. L. Peixoto, Vagner O. C. Rigaud, Paula Buck, Rafael R. Almeida, Hui Tzu Lin-Wang, André Schmidt, Martino Martinelli, Mario H. Hirata, Eduardo Donadi, Virmondes Rodrigues Junior, Alexandre C. Pereira, Jorge Kalil, Lionel Spinelli, Edecio Cunha-Neto, Christophe Chevillard
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chagas disease is a parasitic disease from South America, affecting around 7 million people worldwide. Decades after the infection, 30% of people develop chronic forms, including Chronic Chagas Cardiomyopathy (CCC), for which no treatment exists. Two
Externí odkaz:
https://doaj.org/article/bb254841467843829595af54d0de0b0a
Autor:
Raul Rodriguez‐Esteban, José Duarte, Priscila C. Teixeira, Fabien Richard, Svetlana Koltsova, W. Venus So
Publikováno v:
Cytometry Part B: Clinical Cytometry. 102:220-227
A key step in clinical flow cytometry data analysis is gating, which involves the identification of cell populations. The process of gating produces a set of reportable results, which are typically described by gating definitions. The non-standardize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c56df4b061a395e91a14ccf703aae950
https://doi.org/10.1002/cyto.b.22065
https://doi.org/10.1002/cyto.b.22065
Autor:
Edecio Cunha-Neto, Luciana G Nogueira, Priscila C Teixeira, Rajendranath Ramasawmy, Sandra A Drigo, Anna Carla Goldberg, Simone G Fonseca, Angelina M Bilate, Jorge Kalil
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 104, Pp 252-258 (2009)
The pathogenesis of Chagas disease cardiomyopathy (CCC) is not well understood. Since studies show that myocarditis is more frequent during the advanced stages of the disease, and the prognosis of CCC is worse than that of other dilated cardiomyopath
Externí odkaz:
https://doaj.org/article/f525b52b83ac493a974412df90e105e7
Publikováno v:
Química Nova, Vol 25, Iss 4, Pp 594-608 (2002)
Externí odkaz:
https://doaj.org/article/ab6594c6d25341d19d2555742e7a47bf
Autor:
Edecio, Cunha-Neto, Priscila C, Teixeira, Luciana G, Nogueira, Charles, Mady, Barbara, Lanni, Noedir, Stolf, Alfredo, Fiorelli, Ronaldo, Honorato, Jorge, Kalil
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical. 39
The pathogenesis of chronic Chagas cardiomyopathy (CCC) is still being unraveled. In the last decade, a role for inflammatory cytokines on tissue damage has been shown. The present review will address the molecular and immunological mechanisms of tis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::837e3cd0aa3c831f91fe64b2b7236abf
https://pubmed.ncbi.nlm.nih.gov/17605209
https://pubmed.ncbi.nlm.nih.gov/17605209
Autor:
Janice, Onuki, Priscila C, Teixeira, Marisa H G, Medeiros, Dieter, Dörnemann, Thierry, Douki, Jean, Cadet, Paolo, Di Mascio
Publikováno v:
Cellular and molecular biology (Noisy-le-Grand, France). 48(1)
5-Aminolevulinic acid (ALA) is a heme precursor that accumulates in acute intermittent porphyria (AIP) due to enzymatic deficiencies in the heme biosynthetic pathway Its accumulation has been associated with several symptoms, such as abdominal pain a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::047d03f617e9b422b016282dcb540fc4
https://pubmed.ncbi.nlm.nih.gov/11930945
https://pubmed.ncbi.nlm.nih.gov/11930945
Autor:
Rodriguez‐Esteban, Raul, Duarte, José, Teixeira, Priscila C., Richard, Fabien, Koltsova, Svetlana, So, W. Venus
Publikováno v:
Cytometry. Part B; May2022, Vol. 102 Issue 3, p220-227, 8p
Autor:
Machiels JP; Medical Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium jean-pascal.machiels@uclouvain.be.; UCLouvain, Brussels, Belgium., Gomez-Roca C; Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France., Michot JM; Department of Innovative Therapies and Early Phase trials (DITEP), Gustave Roussy, Villejuif, France., Zamarin D; Memorial Sloan Kettering Cancer Center, New York City, New York, USA., Mitchell T; Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Catala G; Medial Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Eberst L; Department of Medicine, Centre Léon Bérard, Lyon, France., Jacob W; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Jegg AM; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Cannarile MA; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Watson C; A4P Ltd, Sandwich, UK., Babitzki G; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Korski K; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Klaman I; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Teixeira P; Pharma Research and Early Development, Roche Innovation Center Welwyn, Welwyn Garden City, UK., Hoves S; Roche Innovat Ctr Munich Oncol Discovery Pharma, Penzberg, Germany., Ries C; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Meneses-Lorente G; Pharma Research and Early Development, Roche Innovation Center Welwyn, Welwyn Garden City, UK., Michielin F; Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Christen R; Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Rüttinger D; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Weisser M; Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Delord JP; Department of Medicine, Centre Léon Bérard, Lyon, France., Cassier P; Department of Medicine, Centre Léon Bérard, Lyon, France.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Oct; Vol. 8 (2).